Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16,775 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II Study of S-1 Monotherapy as a First-line, Combination Therapy of S-1 plus Cisplatin as a Second-line, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: Phase II Study of S-1, S-1 plus Cisplatin, and Weekly Paclitaxel in Patients with Advanced Gastric Carcinoma.
Rino Y, Yukawa N, Wada N, Suzuki M, Murakami H, Yamada T, Nakayama H, Yamamoto N, Sato T, Yamada R, Ohshima T, Masuda M, Imada T. Rino Y, et al. Among authors: sato t. Clin Med Oncol. 2008;2:375-83. doi: 10.4137/cmo.s610. Epub 2008 Apr 28. Clin Med Oncol. 2008. PMID: 21892302 Free PMC article.
A Phase II Study of S-1 Monotherapy as a First-line Combination Therapy of S-1 Plus Cisplatin as a Second-line Therapy, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: A Second Report.
Rino Y, Yukawa N, Murakami H, Wada N, Yamada R, Hayashi T, Sato T, Ohshima T, Masuda M, Imada T. Rino Y, et al. Among authors: sato t. Clin Med Insights Oncol. 2010 Mar 24;4:1-10. doi: 10.4137/cmo.s3920. Clin Med Insights Oncol. 2010. PMID: 20567630 Free PMC article.
Short-term results of a phase II study of preoperative docetaxel/cisplatin/S-1 therapy for locally advanced gastric cancer.
Tsuchida K, Sato T, Aoyama T, Atsumi Y, Kano K, Maezawa Y, Kazama K, Numata M, Yamada T, Tamagawa H, Murakami H, Oshima T, Saeki H, Cho H, Yukawa N, Yamamoto Y, Masuda M, Rino Y. Tsuchida K, et al. Among authors: sato t. Jpn J Clin Oncol. 2021 Mar 3;51(3):371-378. doi: 10.1093/jjco/hyaa221. Jpn J Clin Oncol. 2021. PMID: 33283236 Free PMC article. Clinical Trial.
Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T, Kunisaki C, Yoshihara K, Yamada R, Yamamoto N, Sato T, Makino H, Yamagishi S, Nagano Y, Fujii S, Shiozawa M, Akaike M, Wada N, Rino Y, Masuda M, Tanaka K, Imada T. Oshima T, et al. Among authors: sato t. Oncol Rep. 2008 May;19(5):1285-91. Oncol Rep. 2008. PMID: 18425389
Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T, Akaike M, Yoshihara K, Shiozawa M, Yamamoto N, Sato T, Yamada R, Fujii S, Rino Y, Kunisaki C, Tanaka K, Masuda M, Imada T. Oshima T, et al. Among authors: sato t. Oncol Rep. 2008 Aug;20(2):359-64. Oncol Rep. 2008. PMID: 18636198
16,775 results
You have reached the last available page of results. Please see the User Guide for more information.